This paper describes the application of flow cytometry to the determination of calcium oxalate crystallization kinetics and mechanisms in real urine. The technique has the unique advantage of simultaneously providing quantitative particle number-size distributions and qualitative data concerning particle structure and morphology. Twenty-four-hour urines from 10 healthy male subjects were treated with sodium oxalate and the ensuing crystallization of calcium oxalate was monitored by flow cytometry. In 7 specimens crystallization was accompanied by increasing size and by a fundamental change in particle morphology. This suggests that nucleation and aggregation occurred in these specimens. In the remaining 3 samples, increasing particle numbers occurred without any changes in size or morphology, indicating that nucleation was the sole mechanism in these specimens. These results demonstrate that flow cytometry is able to differentiate between nucleation, growth and aggregation mechanisms thereby making it an extremely useful analytical tool for stone researchers.

Keywords:
Flow cytometry, Calcium oxalate crystallization kinetics, Calcium oxalate crystallization mechanisms, Urine crystallization, Nucleation Growth, Aggregation
This content is only available via PDF.
© 1995 S. Karger AG, Basel
1995
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.